Gene and human tumour cell line specific differences in nitrogen mustard induced DNA alkylation and interstrand crosslinking frequencies

Nucleic Acids Research

Volumn 26, Issue 24, 1998, Pages 5617-5623

  Sunters, Andrew ^a,b   Grimaldi, Keith A ^a   Souhami, Robert L ^a   Hartley, John A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORMETHINE; DNA; PURINE;

ALLELE; ARTICLE; CONTROLLED STUDY; DNA ALKYLATION; DNA CROSS LINKING; DNA DAMAGE; DRUG SENSITIVITY; EPISOME; GENE AMPLIFICATION; GENE REARRANGEMENT; GENETIC HETEROGENEITY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; ONCOGENE C MYC; ONCOGENE N RAS; PRIORITY JOURNAL; SOUTHERN BLOTTING; TUMOR CELL LINE;

EID: 0032534709     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/26.24.5617     Document Type: Article

References (30)

1. Wilman, D.E.V. and Connors, T.A. (1983) In Neidle, S.N. and Waring, M.J. (eds), Topics in Molecular and Structural Biology. Vol. 3. Verlag Chemie, Weinheim, pp. 233-282.
2. Brookes, P. and Lawley, P.D. (1961) Biochem. J., 80, 496-503.
3. Osborne, M.R., Wilman, D.E.V. and Lawley, P.D. (1995) Chem. Res. Toxicol., 8, 316-320.
4. Hartley, J.A. (1993) In Neidle, S.N. and Waring, M.J. (eds), Molecular Aspects of Anticancer Drug-DNA Interactions. Macmillan, Basingstoke, UK, pp. 1-31.
5. O'Connor, P.M. and Kohn, K.W. (1990) Cancer Commun., 2, 387-394.
6. Sunters, A., Springer, C.J., Bagshawe, K., Souhami, R.L. and Hartley, J.A. (1992) Biochem. Pharmacol., 41, 59-64.
7. Hill, B.T. (1972) Biochem. Pharmacol., 21, 495-502.
8. Hill, B.T., Jarman, M. and Harrap, K.R. (1971) J. Med. Chem., 14, 614-618.
9. Tew, K.T. (1994) Cancer Res., 54, 4313-4320.
10. Batist, G., Torres-Garcia, S., Demuys, J.-M., Greene, D.L.S., Rochon, M. and Panasci, L. (1989) Mol. Pharmacol., 36, 224-230.
11. Bohr, V.A. (1991) Carcinogenesis, 12, 1983-1992.
12. Hanawalt, P.C. (1994) Science, 266, 1957-1958.
13. Wassermann, K., Kohn, K.W. and Bohr, V.A. (1990) J. Biol. Chem., 265, 13906-13913.
14. Wassermann, K. and Damgaard, J. (1994) Cancer Res., 54, 175-181.
15. Futscher, B.W., Pieper, R.O., Dalto, W.S. and Erickson, L.C. (1992) Cell Growth Differ., 3, 217-223.
16. Larminat, F., Zhen, W. and Bohr, V.A. (1993) J. Biol. Chem., 268, 2649-2654.
17. Stevnsner, T., May, A., Petersen, L.N., Larminat, F., Pirsel, M. and Bohr, V.A. (1993) Carcinogenesis, 14, 1591-1596.
18. Sunters, A., Grimaldi, K.A., Souhami, R.L. and Hartley, J.A. (1996) Nucleic Acids Res., 24, 2456-2457.
19. Droczek, R.A. (1993) J. Chromatogr., 618, 133-145.
20. Denziot, F. and Lang, R. (1986) J. Immunol. Methods, 89, 188-193.
21. Larminat, F., Beecham, E.J., Link, C.J., May, A. and Bohr, V.A. (1995) Oncogene, 10, 1639-1645.
22. Wassermann, K., O'Connor, P.M., Jackman, J., May, A. and Bohr, V.A. (1994) Carcinogenesis, 15, 1779-1783.
23. Bartlet, J.D., Scicchitano, D.A. and Robison, S.H. (1991) Mutat. Res., 255, 247-256.
24. Tang, M.S., Qian, M. and Pao, A. (1994) Biochemistry, 33, 2726-2732.
25. Razin, S.V. and Gromova, I.I. (1995) Bioessays, 17, 443-450.
26. Flanagan, B.F., Wotton, D., Tuck-Wah, S. and Owen, M.J. (1990) Immunogenetics, 31, 13-20.
27. Kohn, K.W., Spears, C.L. and Doty, P.D. (1966) J. Mol. Biol., 19, 266-288.
28. Ojwang, J.O., Greuneberg, D.A. and Loechler, E.L. (1989) Cancer Res., 49, 6529-6537.
29. Millard, J.T., Weidner, M.F., Kirchner, J.J., Ribeiro, S. and Hopkins, P.B. (1991) Nucleic Acids Res., 19, 1885-1891.
30. Millard, J.T. and White, M.M. (1993) Biochemistry, 32, 2120-2124.